Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

PHARMACOLOGICAL CHARACTERIZATION OF APROCITENTAN, A DUAL ENDOTHELIN RECEPTOR ANTAGONIST, ALONE AND IN COMBINATION WITH BLOCKERS OF THE RENIN ANGIOTENSIN SYSTEM, IN TWO MODELS OF EXPERIMENTAL HYPERTENSION.

Trensz F, Bortolamiol C, Kramberg M, Wanner D, Hadana H, Rey M, Strasser DS, Delahaye S, Hess P, Vezzali E, Mentzel U, Menard J, Clozel M, Iglarz M.

J Pharmacol Exp Ther. 2019 Jan 8. pii: jpet.118.253864. doi: 10.1124/jpet.118.253864. [Epub ahead of print]

2.

The metabolism and drug-drug interaction potential of the selective prostacyclin receptor agonist selexipag.

Gnerre C, Segrestaa J, Seeland S, Äänismaa P, Pfeifer T, Delahaye S, de Kanter R, Ichikawa T, Yamada T, Treiber A.

Xenobiotica. 2018 Jul;48(7):704-719. doi: 10.1080/00498254.2017.1357088. Epub 2017 Aug 30.

PMID:
28737453
3.

Discriminating Agonist from Antagonist Ligands of the Nuclear Receptors Using Different Chemoinformatics Approaches.

Lagarde N, Delahaye S, Jérémie A, Ben Nasr N, Guillemain H, Empereur-Mot C, Laville V, Labib T, Réau M, Langenfeld F, Zagury JF, Montes M.

Mol Inform. 2017 Oct;36(10). doi: 10.1002/minf.201700020. Epub 2017 Jul 3.

PMID:
28671755
4.

Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores.

Lagarde N, Delahaye S, Zagury JF, Montes M.

J Cheminform. 2016 Sep 6;8(1):43. doi: 10.1186/s13321-016-0154-2. eCollection 2016.

5.

Discovery and Characterization of ACT-451840: an Antimalarial Drug with a Novel Mechanism of Action.

Boss C, Aissaoui H, Amaral N, Bauer A, Bazire S, Binkert C, Brun R, Bürki C, Ciana CL, Corminboeuf O, Delahaye S, Dollinger C, Fischli C, Fischli W, Flock A, Frantz MC, Girault M, Grisostomi C, Friedli A, Heidmann B, Hinder C, Jacob G, Le Bihan A, Malrieu S, Mamzed S, Merot A, Meyer S, Peixoto S, Petit N, Siegrist R, Trollux J, Weller T, Wittlin S.

ChemMedChem. 2016 Sep 20;11(18):1995-2014. doi: 10.1002/cmdc.201600298. Epub 2016 Jul 29.

PMID:
27471138
6.

Effectiveness and complications of ultrasound-guided subclavian vein cannulation in children and neonates.

Nardi N, Wodey E, Laviolle B, De La Brière F, Delahaye S, Engrand C, Gauvrit C, Dessard S, Defontaine A, Ecoffey C.

Anaesth Crit Care Pain Med. 2016 Jun;35(3):209-13. doi: 10.1016/j.accpm.2015.09.007. Epub 2016 Feb 26.

7.

Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug-Drug Interactions.

de Kanter R, Sidharta PN, Delahaye S, Gnerre C, Segrestaa J, Buchmann S, Kohl C, Treiber A.

Clin Pharmacokinet. 2016 Mar;55(3):369-80. doi: 10.1007/s40262-015-0322-y.

PMID:
26385839
8.

Discovery of novel bridged tetrahydronaphthalene derivatives as potent T/L-type calcium channel blockers.

Renneberg D, Hubler F, Rey M, Hess P, Delahaye S, Gatfield J, Iglarz M, Hilpert K.

Bioorg Med Chem Lett. 2015 Sep 15;25(18):3941-6. doi: 10.1016/j.bmcl.2015.07.038. Epub 2015 Jul 21.

PMID:
26231163
9.

Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension.

Iglarz M, Landskroner K, Bauer Y, Vercauteren M, Rey M, Renault B, Studer R, Vezzali E, Freti D, Hadana H, Schläpfer M, Cattaneo C, Bortolamiol C, Weber E, Whitby BR, Delahaye S, Wanner D, Steiner P, Nayler O, Hess P, Clozel M.

J Cardiovasc Pharmacol. 2015 Nov;66(5):457-67. doi: 10.1097/FJC.0000000000000296.

10.

Implementing stationary-phase optimized selectivity in supercritical fluid chromatography.

Delahaye S, Lynen F.

Anal Chem. 2014 Dec 16;86(24):12220-8. doi: 10.1021/ac503313j. Epub 2014 Dec 1.

PMID:
25393519
11.

Macitentan does not interfere with hepatic bile salt transport.

Treiber A, Äänismaa P, de Kanter R, Delahaye S, Treher M, Hess P, Sidharta P.

J Pharmacol Exp Ther. 2014 Jul;350(1):130-43. doi: 10.1124/jpet.114.214106. Epub 2014 Apr 25.

12.

Application of the isopycnic kinetic plot method for elucidating the potential of sub-2 µm and core-shell particles in SFC.

Delahaye S, Broeckhoven K, Desmet G, Lynen F.

Talanta. 2013 Nov 15;116:1105-12. doi: 10.1016/j.talanta.2013.08.023. Epub 2013 Aug 23.

PMID:
24148522
13.

Desensitization by progressive up-titration prevents first-dose effects on the heart: guinea pig study with ponesimod, a selective S1P1 receptor modulator.

Rey M, Hess P, Clozel M, Delahaye S, Gatfield J, Nayler O, Steiner B.

PLoS One. 2013 Sep 12;8(9):e74285. doi: 10.1371/journal.pone.0074285. eCollection 2013.

14.

Design and evaluation of various methods for the construction of kinetic performance limit plots for supercritical fluid chromatography.

Delahaye S, Broeckhoven K, Desmet G, Lynen F.

J Chromatogr A. 2012 Oct 5;1258:152-60. doi: 10.1016/j.chroma.2012.08.040. Epub 2012 Aug 17.

PMID:
22939203
15.

Identification of a new chemical class of antimalarials.

Brunner R, Aissaoui H, Boss C, Bozdech Z, Brun R, Corminboeuf O, Delahaye S, Fischli C, Heidmann B, Kaiser M, Kamber J, Meyer S, Papastogiannidis P, Siegrist R, Voss T, Welford R, Wittlin S, Binkert C.

J Infect Dis. 2012 Sep 1;206(5):735-43. doi: 10.1093/infdis/jis418. Epub 2012 Jun 25.

PMID:
22732921
16.

Impact of non-invasive fetal RhD genotyping on management costs of rhesus-D negative patients: results of a French pilot study.

Benachi A, Delahaye S, Leticee N, Jouannic JM, Ville Y, Costa JM.

Eur J Obstet Gynecol Reprod Biol. 2012 May;162(1):28-32. doi: 10.1016/j.ejogrb.2012.02.001. Epub 2012 Mar 3.

PMID:
22386678
17.

Cobblestone lissencephaly: neuropathological subtypes and correlations with genes of dystroglycanopathies.

Devisme L, Bouchet C, Gonzalès M, Alanio E, Bazin A, Bessières B, Bigi N, Blanchet P, Bonneau D, Bonnières M, Bucourt M, Carles D, Clarisse B, Delahaye S, Fallet-Bianco C, Figarella-Branger D, Gaillard D, Gasser B, Delezoide AL, Guimiot F, Joubert M, Laurent N, Laquerrière A, Liprandi A, Loget P, Marcorelles P, Martinovic J, Menez F, Patrier S, Pelluard F, Perez MJ, Rouleau C, Triau S, Attié-Bitach T, Vuillaumier-Barrot S, Seta N, Encha-Razavi F.

Brain. 2012 Feb;135(Pt 2):469-82. doi: 10.1093/brain/awr357. Epub 2012 Feb 9.

PMID:
22323514
18.

Phenotypic spectrum of fetal Smith-Lemli-Opitz syndrome.

Quélin C, Loget P, Verloes A, Bazin A, Bessières B, Laquerrière A, Patrier S, Grigorescu R, Encha-Razavi F, Delahaye S, Jouannic JM, Carbonne B, D'Hervé D, Aubry MC, Macé G, Harvey T, Ville Y, Viot G, Joyé N, Odent S, Attié-Bitach T, Wolf C, Chevy F, Benlian P, Gonzales M.

Eur J Med Genet. 2012 Feb;55(2):81-90. doi: 10.1016/j.ejmg.2011.12.002. Epub 2011 Dec 22.

19.

First-trimester molecular prenatal diagnosis of a thanatophoric dysplasia.

Delahaye S, Rosenblatt J, Costa JM, Bazin A, Bénifla JL, Jouannic JM.

Prenat Diagn. 2010 Dec;30(12-13):1222-3. doi: 10.1002/pd.2638. No abstract available.

PMID:
20949643
20.

New classes of potent and bioavailable human renin inhibitors.

Remen L, Bezençon O, Richard-Bildstein S, Bur D, Prade L, Corminboeuf O, Boss C, Grisostomi C, Sifferlen T, Strickner P, Hess P, Delahaye S, Treiber A, Weller T, Binkert C, Steiner B, Fischli W.

Bioorg Med Chem Lett. 2009 Dec 1;19(23):6762-5. doi: 10.1016/j.bmcl.2009.09.104. Epub 2009 Oct 1.

PMID:
19853442
21.

Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors.

Bezençon O, Bur D, Weller T, Richard-Bildstein S, Remen L, Sifferlen T, Corminboeuf O, Grisostomi C, Boss C, Prade L, Delahaye S, Treiber A, Strickner P, Binkert C, Hess P, Steiner B, Fischli W.

J Med Chem. 2009 Jun 25;52(12):3689-702. doi: 10.1021/jm900022f.

PMID:
19358611
22.

Early second-trimester diagnosis of intracranial teratoma.

Saada J, Enza-Razavi F, Delahaye S, Martinovic J, Macaleese J, Benachi A.

Ultrasound Obstet Gynecol. 2009 Jan;33(1):109-11. doi: 10.1002/uog.6231.

23.

Reaction of trimethylchlorosilane in spin-on Silicalite-1 zeolite film.

Eslava S, Delahaye S, Baklanov MR, Iacopi F, Kirschhock CE, Maex K, Martens JA.

Langmuir. 2008 May 6;24(9):4894-900. doi: 10.1021/la800086y. Epub 2008 Apr 5.

PMID:
18393487
24.

Nonvisualization of the fetal gallbladder by second-trimester ultrasound scan: strategy of clinical management based on four examples.

Boughanim M, Benachi A, Dreux S, Delahaye S, Muller F.

Prenat Diagn. 2008 Jan;28(1):46-8. doi: 10.1002/pd.1912.

PMID:
18186137
25.

Prenatal diagnosis of dumbbell neuroblastoma.

Delahaye S, Doz F, Sonigo P, Saada J, Mitanchez D, Sarnacki S, Benachi A.

Ultrasound Obstet Gynecol. 2008 Jan;31(1):92-5.

26.

Molecular heterogeneity in fetal forms of type II lissencephaly.

Bouchet C, Gonzales M, Vuillaumier-Barrot S, Devisme L, Lebizec C, Alanio E, Bazin A, Bessières-Grattagliano B, Bigi N, Blanchet P, Bonneau D, Bonnières M, Carles D, Delahaye S, Fallet-Bianco C, Figarella-Branger D, Gaillard D, Gasser B, Guimiot F, Joubert M, Laurent N, Liprandi A, Loget P, Marcorelles P, Martinovic J, Menez F, Patrier S, Pelluard-Nehmé F, Perez MJ, Rouleau-Dubois C, Triau S, Laquerrière A, Encha-Razavi F, Seta N.

Hum Mutat. 2007 Oct;28(10):1020-7.

PMID:
17559086
27.

Matthew-Wood syndrome is caused by truncating mutations in the retinol-binding protein receptor gene STRA6.

Golzio C, Martinovic-Bouriel J, Thomas S, Mougou-Zrelli S, Grattagliano-Bessieres B, Bonniere M, Delahaye S, Munnich A, Encha-Razavi F, Lyonnet S, Vekemans M, Attie-Bitach T, Etchevers HC.

Am J Hum Genet. 2007 Jun;80(6):1179-87. Epub 2007 Apr 11.

28.

Vertebral anomalies and cartilaginous tracheal sleeve in three patients with Pfeiffer syndrome carrying the S351C FGFR2 mutation.

Gonzales M, Heuertz S, Martinovic J, Delahaye S, Bazin A, Loget P, Pasquier L, Le Merrer M, Bonaventure J.

Clin Genet. 2005 Aug;68(2):179-81. No abstract available.

PMID:
15996217
29.

Tuning the decay time of lanthanide-based near infrared luminescence from micro- to milliseconds through d-->f energy transfer in discrete heterobimetallic complexes.

Torelli S, Imbert D, Cantuel M, Bernardinelli G, Delahaye S, Hauser A, Bünzli JC, Piguet C.

Chemistry. 2005 May 20;11(11):3228-42.

PMID:
15779094
30.

[Routine sentinel node detection in breast cancer. Experience of the Curie Institute].

Delahaye S, Benamor M, Nos C, Vincent-Salomon A, El Khoury C, Doridot V, Sigal-Zafrani B, Clough KB; Groupe Sein de l'Institut Curie.

Bull Cancer. 2004 Jul-Aug;91(7-8):641-7. French.

31.

Ruthenium(II) as a novel "labile" partner in thermodynamic self-assembly of heterobimetallic d-f triple-stranded helicates.

Torelli S, Delahaye S, Hauser A, Bernardinelli G, Piguet C.

Chemistry. 2004 Jul 19;10(14):3503-16.

PMID:
15252796
32.

Alkalinization of intra-cuff lidocaine and use of gel lubrication protect against tracheal tube-induced emergence phenomena.

Estebe JP, Delahaye S, Le Corre P, Dollo G, Le Naoures A, Chevanne F, Ecoffey C.

Br J Anaesth. 2004 Mar;92(3):361-6.

33.
34.

[Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].

Jouannic JM, Delahaye S, Le Bidois J, Fermont L, Villain E, Dommergues M, Dumez Y.

J Gynecol Obstet Biol Reprod (Paris). 2003 Jun;32(4):338-44. French.

35.

Prenatal ultrasound diagnosis of fetal craniosynostosis.

Delahaye S, Bernard JP, Rénier D, Ville Y.

Ultrasound Obstet Gynecol. 2003 Apr;21(4):347-53.

36.

No influence of the endothelin receptor antagonist bosentan on basal and indomethacin-induced reduction of cerebral blood flow in pigs.

Rasmussen M, Poulsen PH, Treiber A, Delahaye S, Tankisi A, Cold GE, Therkelsen K, Gjedde A, Astrup J.

Acta Anaesthesiol Scand. 2003 Feb;47(2):200-7.

PMID:
12631050
37.

Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy?

Jouannic JM, Delahaye S, Fermont L, Le Bidois J, Villain E, Dumez Y, Dommergues M.

Prenat Diagn. 2003 Feb;23(2):152-6.

PMID:
12575024
38.

[Comments on the Perruche decree].

Delahaye S, Ville Y.

J Gynecol Obstet Biol Reprod (Paris). 2002 Jun;31(4):397-400. French. No abstract available.

39.

A one-hour procedure for the preparation of genomic DNA from frozen tissues.

Chapdelaine P, Delahaye S, Gauthier E, Tremblay RR, Dubé JY.

Biotechniques. 1993 Feb;14(2):163-4. No abstract available.

PMID:
8431273

Supplemental Content

Loading ...
Support Center